Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Am J Clin Pathol. 2010 Feb;133(2):265–270. doi: 10.1309/AJCPUS3PRRT5ZXVS

Figure 2.

Figure 2

Box plots comparing the messenger RNA expression of MS4A1/CD20 (A), PAX5 (B), and VPREB3 (C), as determined by microarray, in small lymphocyte–like plasma cell myeloma (SLM) CD-2 subtype (n = 9), non-SLM CD-2 (n = 20), and others (n = 322). Note that there is no significant difference in the expression of these genes within the CD-2 class but that expression is significantly lower in the other classes relative to the SLM and non-SLM CD-2 classes.